These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8026687)

  • 1. [Platelet transfusions in systemic blood diseases].
    Agranenko VA; Kompaniets AM; Kaveshnikova BF
    Gematol Transfuziol; 1994; 39(2):32-7. PubMed ID: 8026687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
    Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
    Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet utilization in a university hospital.
    McCullough J; Steeper TA; Connelly DP; Jackson B; Huntington S; Scott EP
    JAMA; 1988 Apr 22-29; 259(16):2414-8. PubMed ID: 3352130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Survey on the threshold for platelet transfusions].
    Hiruma K; Okuyama Y; Osaka A; Kasai M; Kodo H; Takamoto S; Handa M; Fujii H; Muto Y; Mori M; Shimizu M
    Rinsho Ketsueki; 2004 Nov; 45(11):1187-92. PubMed ID: 15609685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet transfusions in haematology patients: are we using them appropriately?
    Estcourt LJ; Birchall J; Lowe D; Grant-Casey J; Rowley M; Murphy MF
    Vox Sang; 2012 Nov; 103(4):284-93. PubMed ID: 22775395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indications for therapeutic platelet transfusions.
    Hunt BJ
    Blood Rev; 1998 Dec; 12(4):227-33. PubMed ID: 9950092
    [No Abstract]   [Full Text] [Related]  

  • 7. Transfusion of ABO non-identical platelets does not influence the clinical outcome of patients undergoing autologous haematopoietic stem cell transplantation.
    Solves P; Carpio N; Balaguer A; Romero S; Iacoboni G; Gómez I; Lorenzo I; Moscardó F; Sanz J; Lopez F; Martin G; Jarque I; Montesinos P; De La Rubia J; Sanz G; Sanz MA
    Blood Transfus; 2015 Jul; 13(3):411-6. PubMed ID: 25761311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogen-reduced platelets for the prevention of bleeding.
    Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet transfusions: treatment options for hemorrhage secondary to thrombocytopenia.
    Hux BD; Martin LG
    J Vet Emerg Crit Care (San Antonio); 2012 Feb; 22(1):73-80. PubMed ID: 23016744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical aspects of platelet transfusions.
    Murphy MF; Waters AH
    Blood Coagul Fibrinolysis; 1991 Apr; 2(2):389-96. PubMed ID: 1893071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.
    Trial to Reduce Alloimmunization to Platelets Study Group
    N Engl J Med; 1997 Dec; 337(26):1861-9. PubMed ID: 9417523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants.
    Asano H; Lee CY; Fox-Talbot K; Koh CM; Erdinc MM; Marschner S; Keil S; Goodrich RP; Baldwin WM
    Transplantation; 2007 Nov; 84(9):1174-82. PubMed ID: 17998874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet refractoriness and alloimmunization in pediatric oncology and bone marrow transplant patients.
    Hogge DE; McConnell M; Jacobson C; Sutherland HJ; Benny WB; Massing BG
    Transfusion; 1995 Aug; 35(8):645-52. PubMed ID: 7631404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
    Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
    Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion Management in Pediatric Oncology Patients.
    Nellis ME; Goel R; Karam O
    Hematol Oncol Clin North Am; 2019 Oct; 33(5):903-913. PubMed ID: 31466612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet transfusions in children: results of a randomized, prospective, crossover trial of plasma removal and a prospective audit of WBC reduction.
    Couban S; Carruthers J; Andreou P; Klama LN; Barr R; Kelton JG; Heddle NM
    Transfusion; 2002 Jun; 42(6):753-8. PubMed ID: 12147029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABO compatibility can influence the results of platelet transfusion. Results of a randomized trial.
    Lee EJ; Schiffer CA
    Transfusion; 1989 Jun; 29(5):384-9. PubMed ID: 2660333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Guide for transfusion of red blood cells, platelets and labile plasma products. Joint directive of the Spanish society of blood transfusion].
    Algora Weber M; Fernández Montoya A; Gómez Villagrán JL; Martín Vega C; Prats Arrojo I; Puig Alcaraz N; Pujol Bosch M; Vesga Carasa MA
    Med Clin (Barc); 1999 Oct; 113(12):471-4. PubMed ID: 10570517
    [No Abstract]   [Full Text] [Related]  

  • 19. D+ platelet transfusions in D- patients: cause for concern?
    Bartley AN; Carpenter JB; Berg MP
    Immunohematology; 2009; 25(1):5-8. PubMed ID: 19856725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelets Structure, Function and Modulator Capacity in Replacement Therapy.
    Moutinho B; Pinto B; Cardoso R; Botelho MC
    Cardiovasc Hematol Disord Drug Targets; 2017; 17(3):180-184. PubMed ID: 29283062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.